ThirdLaw Molecular
ThirdLaw Molecular is a startup headquartered in Blue Bell, United States, founded in 2024. It has raised at least $5.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
ThirdLaw Molecular has raised at least $5.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
ThirdLaw Molecular sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Related
- Innovation profile of Blue Bell
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does ThirdLaw Molecular do?
ThirdLaw Molecular is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has ThirdLaw Molecular raised?
At least $5.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is ThirdLaw Molecular based?
ThirdLaw Molecular is headquartered in Blue Bell, United States.
When was ThirdLaw Molecular founded?
ThirdLaw Molecular was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.